Reference system for characterization of Bordetella pertussis pulsed-field gel electrophoresis profiles

被引:60
作者
Advani, A [1 ]
Donnelly, D [1 ]
Hallander, H [1 ]
机构
[1] Swedish Inst Infect Dis Control, Dept Immunol & Vaccine Res, S-17182 Solna, Sweden
关键词
D O I
10.1128/JCM.42.7.2890-2897.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Pulsed-field gel electrophoresis (PFGE) has been used as an epidemiological tool for surveillance studies of Bordetella pertussis since the early 1990s. To date there is no standardized procedure for comparison of results, and therefore it has been difficult to directly compare PFGE results between laboratories. We propose a profile-based reference system for PFGE characterization of B. pertussis strain variation and to establish traceability of B. pertussis PFGE results. We initially suggest 35 Swedish reference strains as reference material for PFGE traceability. This reference material is deposited at the Culture Collection of the University of Gothenburg, Gothenburg, Sweden. Altogether, 1,810 Swedish clinical isolates from between 1970 and 2003 were studied, together with the Swedish Pw vaccine strain, six reference strains, and two U.S. isolates. Our system provides evidence that profiles obtained by using only one enzyme, i.e., XbaI, give enough data to analyze the epidemiological relationship between them. Characterization with one enzyme is far less labor intensive, yielding results in half the time than when a two-enzyme procedure is used. Also, we can see that there is a correlation between PFGE profile and pertactin type. One common PFGE profile, BpSR11 (n = 455), showed 100% prn2 and 100% Fim3 when analyzed for pertactin type and serotype. On the other hand, strains with the same profile may express various serotypes when isolated over longer periods of time. Subculturing of the same isolate eight times or lyophilization caused no change in PFGE profile.
引用
收藏
页码:2890 / 2897
页数:8
相关论文
共 29 条
[1]  
Andrews R, 1997, Commun Dis Intell, V21, P145
[2]   ANALYSIS OF BORDETELLA-PERTUSSIS ISOLATES FROM AN EPIDEMIC BY PULSED-FIELD GEL-ELECTROPHORESIS [J].
BEALL, B ;
CASSIDAY, PK ;
SANDEN, GN .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (12) :3083-3086
[3]   Molecular epidemiology of Bordetella pertussis by pulsed-field gel electrophoresis profile:: Cincinnati, 1989-1996 [J].
Bisgard, KM ;
Christie, CDC ;
Reising, SF ;
Sanden, GN ;
Cassiday, PK ;
Gomersall, C ;
Wattigney, WA ;
Roberts, NE ;
Strebel, PM .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (09) :1360-1367
[4]   Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999 [J].
Cassiday, P ;
Sanden, G ;
Heuvelman, K ;
Mooi, F ;
Bisgard, KM ;
Popovic, T .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (05) :1402-1408
[5]   Pertussis in the Netherlands: An outbreak despite high levels of immunization with whole-cell vaccine [J].
deMelker, HE ;
ConynvanSpaendonck, MAE ;
Rumke, H ;
vanWijngaarden, JK ;
Mooi, FR ;
Schellekens, JFP .
EMERGING INFECTIOUS DISEASES, 1997, 3 (02) :175-178
[6]   USE OF PULSED-FIELD GEL-ELECTROPHORESIS FOR EPIDEMIOLOGIC-STUDY OF BORDETELLA-PERTUSSIS IN A WHOOPING-COUGH OUTBREAK [J].
DEMOISSAC, YR ;
RONALD, SL ;
PEPPLER, MS .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (02) :398-402
[7]   Seroepidemiology of Bordetella pertussis infections in the Spanish population:: a cross-sectional study [J].
García-Corbeira, P ;
Dal-Ré, R ;
Aguilar, L ;
García-de-Lomas, J .
VACCINE, 2000, 18 (21) :2173-2176
[8]   Fimbrial typing of Bordetella pertussis isolates:: Agglutination with polyclonal and monoclonal antisera [J].
Guiso, N ;
von Konig, CHW ;
Becker, C ;
Hallander, H .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (04) :1684-1685
[9]   Changing epidemiology of pertussis in the United States:: Increasing reported incidence among adolescents and adults, 1990-1996 [J].
Güris, D ;
Strebel, PM ;
Bardenheier, B ;
Brennan, M ;
Tachdjian, R ;
Finch, E ;
Wharton, M ;
Livengood, JR .
CLINICAL INFECTIOUS DISEASES, 1999, 28 (06) :1230-1237
[10]   A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine [J].
Gustafsson, L ;
Hallander, HO ;
Olin, P ;
Reizenstein, E ;
Storsaeter, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (06) :349-355